marketcaparena
Search

    SMTI

    Sanara MedTech Inc.

    Company overview

    Market capitalization
    $322.50M
    Employees
    108
    Latest publication
    2026-09-29
    About Sanara MedTech Inc.

    Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue28,136,757USD27,798,534USD27,545,815USD26,333,819USD25,830,834USD23,434,096USD26,305,365USD21,671,599USD
    Cost Of Revenue1,981,347USD2,510,841USD2,542,902USD2,485,113USD1,937,282USD2,528,999USD2,249,182USD1,991,987USD
    Gross Profit26,155,410USD25,287,693USD25,002,913USD23,848,706USD23,893,552USD20,905,097USD24,056,183USD19,679,612USD
    Research Development1,154,232USD759,592USD2,035,737USD1,029,590USD1,257,475USD1,114,138USD2,411,883USD1,359,530USD
    Selling General Administrative5,733,083USD21,881,520USD20,075,597USD19,877,875USD21,553,194USD21,440,610USD22,416,741USD18,993,255USD
    Selling And Marketing Expenses16,868,607USD———————
    General And Administrative Expenses5,733,083USD———————
    Total Operating Expenses24,375,033USD22,641,112USD22,111,334USD20,887,466USD23,924,900USD20,079,567USD24,431,067USD21,603,639USD
    Operating Income1,780,377USD2,646,581USD2,891,579USD2,961,240USD-31,348USD825,530USD-374,884USD-1,924,027USD
    Total Other Income Expense Net-2,191,521USD-2,248,894USD-3,998,889USD-2,126,747USD-1,987,050USD-1,446,096USD-1,325,717USD-959,025USD
    Interest Expense1,810,311USD1,799,345USD1,833,035USD1,818,105USD1,791,568USD1,317,092USD1,289,136USD927,577USD
    Equity Method Income Loss-433,648USD———————
    Discontinued Operations-41,720USD———————
    Net Income-452,864USD458,957USD-1,609,914USD-30,411,153USD-2,014,362USD-3,525,919USD-1,538,581USD-2,857,768USD
    Interest Income—12,958USD0USD0USD0USD3,672USD—0USD
    Net Interest Income—-1,786,387USD-1,833,035USD-1,818,105USD-1,791,568USD-1,313,420USD-1,267,158USD-927,577USD
    Income Before Tax—397,687USD-1,107,310USD834,493USD-2,018,398USD-620,566USD-1,700,601USD-2,883,052USD
    Net Income From Continuing Ops—397,687USD-1,107,310USD834,493USD-2,018,398USD-3,527,383USD-1,700,601USD-2,883,052USD
    Ebit—2,646,581USD2,891,579USD2,961,240USD-31,348USD825,530USD-411,465USD-1,347,008USD
    Ebitda—3,233,833USD3,559,975USD3,572,139USD1,082,883USD1,949,940USD1,196,978USD-243,154USD
    Depreciation And Amortization—587,252USD668,396USD610,899USD1,114,231USD1,124,410USD1,608,443USD1,103,854USD
    Reconciled Depreciation—587,252USD668,396USD1,038,928USD1,114,231USD1,124,410USD1,608,443USD1,103,854USD
    Minority Interest—354USD244USD955USD4,036USD206USD162,020USD25,284USD
    Unclassified Operating Expenses————1,114,231USD-2,475,181USD—1,250,854USD
    Income Tax Expense——————34,859USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue103,117,982USD86,672,425USD64,989,841USD45,842,845USD24,143,919USD15,586,976USD11,766,763USD5,837,839USD
    Cost Of Revenue10,182,842USD8,139,901USD7,852,686USD6,360,851USD2,311,221USD1,616,625USD1,209,300USD507,418USD
    Gross Profit92,935,140USD78,532,524USD57,137,155USD39,481,994USD21,832,698USD13,970,351USD10,557,463USD5,330,421USD
    Research Development5,072,483USD5,703,362USD4,132,424USD3,367,032USD558,704USD40,190USD——
    Selling General Administrative78,716,999USD76,559,863USD54,768,794USD45,976,328USD28,053,176USD18,673,404USD13,067,569USD5,735,833USD
    Total Operating Expenses83,789,482USD85,247,998USD61,352,308USD51,999,174USD29,208,855USD19,004,964USD13,297,520USD5,819,723USD
    Operating Income9,145,658USD-6,715,474USD-4,215,153USD-12,517,180USD-7,376,157USD-5,034,613USD-2,740,057USD-501,860USD
    Interest Income3,672USD21,978USD0USD—————
    Interest Expense6,759,800USD3,128,395USD475,783USD284,746USD711USD11,528USD105,919USD86,587USD
    Net Interest Income-6,756,128USD-3,106,417USD-473,046USD-284,746USD-711USD-11,528USD-105,919USD-86,587USD
    Income Before Tax-393,124USD-9,911,898USD-4,439,902USD-13,937,124USD-7,993,795USD-4,445,145USD-2,835,778USD-600,574USD
    Net Income-37,562,606USD-9,664,547USD-4,303,197USD-7,937,497USD-7,921,914USD-4,356,440USD-2,814,088USD-600,574USD
    Net Income From Continuing Ops-393,124USD-9,911,898USD-8,340,943USD-8,092,328USD-7,993,795USD-4,445,145USD-2,835,778USD-600,574USD
    Ebit9,145,658USD-6,783,503USD-3,964,123USD-13,937,124USD-7,993,084USD-4,433,617USD-2,729,859USD-474,906USD
    Ebitda11,807,531USD-1,860,279USD-289,097USD-11,566,056USD-7,221,154USD-4,142,247USD-2,609,908USD-417,970USD
    Depreciation And Amortization2,661,873USD4,923,224USD3,675,026USD2,371,068USD771,930USD291,370USD119,951USD56,936USD
    Reconciled Depreciation3,945,965USD4,923,224USD3,394,559USD2,371,068USD596,975USD291,370USD119,951USD83,891USD
    Total Other Income Expense Net-9,538,782USD-3,196,424USD-224,749USD-1,419,944USD-617,638USD589,468USD-95,721USD-98,714USD
    Minority Interest5,441USD247,351USD167,801USD-154,831USD71,881USD-310,395USD-221,690USD-221,690USD
    Unclassified Operating Expenses—2,984,773USD2,451,090USD2,655,814USD————
    Income Tax Expense—247,351USD-136,705USD-5,844,796USD-688,097USD-62,355USD94,427USD12,558USD
    Tax Provision——0USD-5,844,796USD0USD———
    Non Operating Income Net Other———-1,704,690USD—589,468USD——
    Net Income Applicable To Common Shares———-7,937,497USD-7,921,914USD-4,356,440USD-2,814,088USD138,286USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets69,146,387USD69,277,117USD72,944,071USD71,088,648USD98,767,645USD96,378,581USD88,091,992USD88,545,476USD
    Cash And Equivalents15,421,170USD———————
    Long Term Investments13,730,703USD14,164,351USD14,626,858USD12,588,476USD10,515,812USD10,690,283USD8,297,223USD8,321,412USD
    Total Current Assets32,200,678USD31,197,982USD33,542,163USD31,225,679USD33,669,456USD36,842,548USD33,305,988USD31,908,408USD
    Other Current Assets741,733USD865,321USD1,016,483USD814,232USD1,200,083USD1,091,039USD1,123,798USD429,428USD
    Total Liabilities61,211,927USD———————
    Total Current Liabilities12,493,991USD13,700,842USD18,626,530USD17,357,969USD14,875,844USD13,281,055USD15,290,071USD14,339,827USD
    Total Stockholder Equity7,943,480USD7,028,515USD5,929,776USD6,140,534USD35,399,412USD36,671,008USD39,403,573USD39,783,866USD
    Total Equity Including Noncontrolling Interest7,934,460USD———————
    Long Term Debt46,477,087USD46,226,422USD45,970,937USD45,089,787USD44,216,662USD43,402,223USD30,689,290USD30,076,715USD
    Net Receivables12,572,651USD13,617,407USD11,998,075USD12,085,845USD11,998,779USD11,904,321USD13,550,863USD12,193,442USD
    Inventory3,459,921USD3,120,795USD3,948,748USD3,385,956USD3,511,850USD3,159,382USD2,753,032USD3,008,349USD
    Property Plant Equipment Net2,336,212USD2,452,730USD2,532,596USD2,571,929USD9,988,028USD3,229,972USD1,880,224USD2,684,733USD
    Goodwill3,601,781USD———————
    Intangible Assets17,277,013USD17,860,273USD18,640,673USD21,100,783USD40,992,568USD42,013,997USD41,006,776USD42,029,142USD
    Accounts Payable1,401,443USD921,243USD2,338,761USD1,167,133USD1,457,301USD2,095,600USD1,499,764USD1,451,973USD
    Short Term Debt383,153USD367,945USD353,229USD338,990USD182,935USD229,710USD358,687USD439,129USD
    Common Stock9,194USD9,166USD8,948USD8,931USD8,904USD8,904USD8,754USD8,743USD
    Retained Earnings-74,891,763USD-74,502,895USD-75,303,042USD-73,693,846USD-43,287,572USD-41,311,569USD-37,784,392USD-36,246,405USD
    Total Liab—62,257,622USD67,014,295USD64,948,114USD63,375,700USD59,711,004USD49,180,030USD49,091,201USD
    Other Current Liab—12,411,654USD14,701,061USD15,851,846USD13,235,608USD10,955,745USD13,431,620USD12,448,725USD
    Capital Stock—9,166USD8,948USD8,931USD8,904USD8,904USD8,754USD8,743USD
    Good Will—3,601,781USD3,601,781USD3,601,781USD3,601,781USD3,601,781USD3,601,781USD3,601,781USD
    Cash—13,594,459USD16,578,857USD14,939,646USD16,958,744USD20,687,806USD15,878,295USD16,277,189USD
    Cash And Short Term Investments—13,594,459USD16,578,857USD14,939,646USD16,958,744USD20,687,806USD15,878,295USD16,277,189USD
    Net Debt—34,770,664USD31,614,012USD32,452,606USD28,492,143USD24,032,074USD16,406,733USD15,645,819USD
    Short Long Term Debt Total—48,365,123USD48,192,869USD47,392,252USD45,450,887USD44,719,880USD32,285,028USD31,923,008USD
    Property Plant Equipment Gross—3,167,207USD3,205,468USD3,202,396USD10,576,936USD3,773,530USD2,488,837USD4,276,719USD
    Common Stock Shares Outstanding—8,985,866shares8,623,028shares8,940,734shares8,612,986shares8,570,104shares8,531,507shares8,517,381shares
    Non Current Assets Total—38,079,135USD39,401,907USD39,862,969USD65,098,189USD59,536,033USD54,786,004USD56,637,068USD
    Non Current Liabilities Total—48,556,780USD48,387,765USD47,590,145USD48,499,856USD46,429,949USD33,889,959USD34,751,374USD
    Non Current Liabilities Other—559,602USD548,125USD536,883USD3,231,903USD1,939,779USD1,963,618USD3,267,495USD
    Non Currrent Assets Other—-31,197,982USD—-31,225,679USD-33,669,456USD—-33,305,988USD-31,908,408USD
    Net Working Capital—17,497,140USD14,915,633USD13,867,710USD18,793,612USD23,561,493USD18,015,917USD17,568,581USD
    Unclassified Non Current Liabilities—1,770,756USD1,868,703USD1,963,475USD1,051,291USD1,087,947USD1,237,051USD1,407,164USD
    Unclassified Equity—81,513,078USD81,214,922USD79,816,518USD78,669,176USD77,964,769USD77,170,457USD76,012,785USD
    Current Deferred Revenue——1,233,478USD—————
    Accumulated Other Comprehensive Income————0USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets72,944,071USD88,091,992USD73,871,149USD61,035,386USD36,396,431USD9,826,221USD11,117,162USD3,042,040USD
    Intangible Assets18,640,673USD41,006,776USD44,926,061USD31,509,980USD4,727,970USD3,097,666USD1,471,194USD52,266USD
    Other Current Assets1,016,483USD1,123,798USD608,411USD1,104,611USD917,318USD611,817USD161,902USD31,926USD
    Total Liab67,014,295USD49,180,030USD29,283,132USD19,315,411USD6,244,427USD3,985,985USD4,724,762USD1,929,982USD
    Total Stockholder Equity5,929,776USD39,403,573USD44,832,277USD41,827,530USD30,640,401USD6,150,631USD6,614,090USD1,112,058USD
    Other Current Liab14,701,061USD13,431,620USD8,776,770USD11,065,639USD5,225,013USD2,919,468USD2,116,116USD349,825USD
    Common Stock8,948USD8,754USD8,535USD8,300USD7,677USD6,297USD3,571USD236,647USD
    Capital Stock8,948USD8,754USD8,535USD8,300USD7,677USD6,297USD11,371,721USD236,647USD
    Retained Earnings-75,303,042USD-37,784,392USD-28,036,814USD-23,394,757USD-15,235,044USD-7,032,242USD-2,675,802USD-47,469,017USD
    Good Will3,601,781USD3,601,781USD3,601,781USD3,601,781USD0USD———
    Cash16,578,857USD15,878,295USD5,147,216USD8,958,995USD18,652,841USD455,366USD6,611,928USD731,849USD
    Cash And Short Term Investments16,578,857USD15,878,295USD5,147,216USD8,958,995USD18,652,841USD455,366USD6,611,928USD731,849USD
    Total Current Assets33,542,163USD33,305,988USD19,005,869USD20,616,509USD24,608,495USD4,482,313USD8,855,764USD978,484USD
    Total Current Liabilities18,626,530USD15,290,071USD13,767,877USD12,806,309USD6,022,276USD3,539,895USD2,639,821USD404,004USD
    Current Deferred Revenue1,233,478USD—2,047,678USD————10,474USD
    Net Debt31,614,012USD16,406,733USD6,644,894USD-8,139,771USD-18,227,398USD26,018USD-4,513,011USD768,151USD
    Short Term Debt353,229USD358,687USD941,542USD313,933USD203,292USD125,587USD117,533USD10,474USD
    Short Long Term Debt Total48,192,869USD32,285,028USD11,792,110USD819,224USD425,443USD481,384USD2,098,917USD1,500,000USD
    Long Term Debt45,970,937USD30,689,290USD9,113,123USD———1,500,000USD1,500,000USD
    Long Term Investments14,626,858USD8,297,223USD3,084,278USD3,084,278USD5,017,351USD1,100,000USD—1,958,463USD
    Net Receivables11,998,075USD13,550,863USD8,532,709USD7,003,903USD2,990,145USD2,266,877USD1,335,415USD214,709USD
    Inventory3,948,748USD2,753,032USD4,717,533USD3,549,000USD2,048,191USD1,148,253USD746,519USD465,314USD
    Accounts Payable2,338,761USD1,499,764USD2,001,887USD1,426,737USD593,971USD494,840USD406,172USD54,179USD
    Property Plant Equipment Net2,532,596USD1,880,224USD3,253,160USD2,222,838USD2,042,615USD1,146,242USD790,204USD52,827USD
    Property Plant Equipment Gross3,205,468USD2,488,837USD4,449,284USD2,962,824USD2,385,189USD1,146,242USD790,204USD52,827USD
    Common Stock Shares Outstanding8,623,028shares8,484,224shares8,278,949shares7,906,794shares7,341,580shares5,734,537shares2,132,745shares2,171,635shares
    Non Current Assets Total39,401,907USD54,786,004USD54,865,280USD40,418,877USD11,787,936USD5,343,908USD2,261,398USD2,063,556USD
    Non Current Liabilities Total48,387,765USD33,889,959USD15,515,255USD6,509,102USD222,151USD446,090USD2,084,941USD1,525,978USD
    Non Current Liabilities Other548,125USD1,963,618USD4,664,687USD6,509,102USD—90,293USD——
    Net Working Capital14,915,633USD18,015,917USD5,237,992USD7,810,200USD18,586,219USD942,418USD6,215,943USD574,480USD
    Unclassified Non Current Liabilities1,868,703USD1,237,051USD1,737,445USD-6,003,811USD————
    Unclassified Equity81,214,922USD77,170,457USD72,852,021USD65,205,687USD45,860,091USD13,170,279USD-2,024,706USD48,177,897USD
    Non Currrent Assets Other—-33,305,988USD-19,005,869USD-40,418,877USD-11,787,936USD-5,343,908USD-2,261,398USD979,979USD
    Short Long Term Debt——580,357USD—————
    Accumulated Other Comprehensive Income——0USD—0USD0USD-60,694USD-70,116USD
    Other Liab———6,003,811USD—90,293USD103,557USD25,978USD
    Net Tangible Assets———6,715,769USD25,912,431USD3,052,965USD-6,225,254USD-10,781,353USD
    Short Term Investments—————1,100,000USD——
    Unclassified Current Assets—————-1,100,000USD——
    Other Assets———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income458,603USD-22,947,941USD833,537USD-2,014,362USD-3,527,383USD-1,700,601USD-2,883,052USD-3,504,014USD
    Depreciation587,252USD25,634,916USD610,899USD1,187,772USD1,124,410USD1,608,443USD1,103,854USD1,203,307USD
    Stock Based Compensation1,028,335USD-2,021,630USD1,232,445USD1,435,439USD1,304,904USD1,195,686USD1,025,431USD1,411,545USD
    Other Non Cash Items964,689USD8,341,709USD-1,548,175USD745,320USD1,476,614USD-512,437USD981,661USD208,452USD
    Change To Account Receivables-1,709,332USD4,138,126USD-260,963USD-209,459USD366,030USD-1,728,872USD-581,877USD-1,480,283USD
    Change To Inventory765,153USD691,171USD8,278USD-525,147USD-605,628USD89,821USD459,626USD500,148USD
    Change In Working Capital-5,504,286USD-5,048,209USD2,280,180USD1,309,842USD-2,377,429USD340,956USD1,822,575USD-731,220USD
    Total Cash From Operating Activities-2,465,407USD3,945,061USD2,176,441USD2,664,011USD-1,998,884USD932,047USD2,050,469USD-1,411,930USD
    Capital Expenditures-43,772USD-82,161USD-1,059,481USD-1,761,359USD-1,722,649USD-95,624USD-9,096USD-58,762USD
    Free Cash Flow-2,509,179USD3,862,900USD1,116,960USD902,652USD-3,721,533USD836,423USD2,041,373USD-1,470,692USD
    Investments0USD-2,363,118USD-3,420,790USD-3,927,968USD-5,179,855USD-129,994USD-6,357,069USD-58,762USD
    Total Cashflows From Investing Activities-43,772USD-2,445,277USD-3,420,790USD-3,927,968USD-5,179,855USD-129,994USD-6,357,069USD-58,762USD
    Net Borrowings0USD0USD0USD-1,694,433USD12,066,250USD0USD15,226,513USD—
    Total Cash From Financing Activities-475,219USD139,427USD-774,749USD-2,465,105USD11,988,250USD-1,200,947USD14,433,414USD4,792,833USD
    Change In Cash-2,984,398USD1,639,211USD-2,019,098USD-3,729,062USD4,809,511USD-398,894USD10,126,814USD3,322,141USD
    Begin Period Cash Flow16,578,857USD14,939,646USD16,958,744USD20,687,806USD15,878,295USD16,277,189USD6,150,375USD2,828,234USD
    End Period Cash Flow13,594,459USD16,578,857USD14,939,646USD16,958,744USD20,687,806USD15,878,295USD16,277,189USD6,150,375USD
    Other Cashflows From Financing Activities-475,219USD12,161,244USD-774,749USD-2,420,672USD-78,000USD-1,200,947USD-718,099USD4,792,833USD
    Other Cashflows From Investing Activities—-17,093,328USD-5,818,513USD-44,463USD60,000USD-23,452USD-1,079,391USD—
    Unclassified Investing Cash Flow—17,093,330USD6,877,994USD1,805,822USD1,662,649USD—1,088,487USD—
    Unclassified Financing Cash Flow—-12,021,817USD—1,650,000USD————
    Unclassified Operating Cash Flow——-1,232,445USD—————
    Issuance Of Capital Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-27,656,149USD-9,911,898USD-4,439,902USD-8,092,328USD-7,993,795USD-4,445,145USD-2,835,778USD-600,574USD
    Depreciation28,557,997USD4,923,224USD3,675,026USD2,371,068USD596,975USD291,370USD119,951USD83,891USD
    Stock Based Compensation718,713USD4,436,048USD3,442,722USD2,702,633USD2,668,892USD1,402,897USD—14,867USD
    Other Non Cash Items9,015,468USD1,440,561USD-2,644,140USD2,790,932USD1,095,285USD-106,075USD407,329USD87,714USD
    Change To Account Receivables4,033,734USD-4,541,124USD-1,731,747USD-2,268,984USD-774,805USD-961,462USD-324,368USD609,233USD
    Change To Inventory-431,326USD1,442,744USD-1,545,339USD-517,271USD-1,151,764USD-719,810USD-401,647USD262,886USD
    Change In Working Capital-3,835,616USD-911,719USD-3,279,262USD517,621USD-1,181,883USD-1,177,565USD141,097USD706,111USD
    Total Cash From Operating Activities6,786,629USD-23,784USD-3,245,556USD-5,554,870USD-4,814,526USD-4,034,518USD-2,167,401USD277,142USD
    Capital Expenditures-4,625,650USD-229,300USD-265,246USD-747,015USD-750,453USD-1,644,374USD-1,705,310USD-8,482USD
    Free Cash Flow2,160,979USD-253,084USD-3,510,802USD-6,301,885USD-5,564,979USD-5,678,892USD-3,872,711USD268,660USD
    Investments-8,262,642USD-6,611,643USD-10,530,024USD-250,000USD-5,284,731USD-2,744,374USD-1,100,000USD-1,100,000USD
    Total Cashflows From Investing Activities-8,362,247USD-6,611,643USD-10,207,346USD-3,511,630USD-5,284,731USD-2,744,374USD-1,197,097USD-8,482USD
    Net Borrowings10,371,817USD19,589,260USD9,688,341USD0USD0USD583,000USD583,000USD583,000USD
    Total Cash From Financing Activities-8,478,683USD17,366,506USD9,641,123USD-627,346USD28,296,732USD622,330USD9,800,005USD-208,102USD
    Change In Cash-10,030,517USD10,731,079USD-3,811,779USD-9,693,846USD18,197,475USD-6,156,562USD6,435,507USD268,660USD
    Begin Period Cash Flow10,731,079USD5,147,216USD8,958,995USD18,652,841USD455,366USD6,611,928USD176,421USD463,189USD
    End Period Cash Flow699,708USD15,878,295USD5,147,216USD8,958,995USD18,652,841USD455,366USD6,611,928USD731,849USD
    Other Cashflows From Investing Activities-10,466,148USD-1,102,843USD650USD-598,451USD-578,586USD-1,100,000USD-1,523,245USD—
    Other Cashflows From Financing Activities-8,478,683USD-2,147,754USD-958,589USD-627,346USD-642,525USD39,330USD9,800,005USD208,102USD
    Unclassified Investing Cash Flow14,992,193USD1,332,143USD—-1,916,164USD1,329,039USD2,744,374USD3,131,458USD1,100,000USD
    Unclassified Financing Cash Flow-10,371,817USD———29,824,307USD—9,417,005USD—
    Issuance Of Capital Stock——1,033,761USD751,752USD28,939,257USD0USD—0USD
    Change To Liabilities———2,692,546USD99,131USD88,668USD-84,636USD346,221USD
    Dividends Paid———-220,000USD-442,525USD-583,000USD-9,998,944USD-223,109USD
    Cash And Cash Equivalents Changes———-9,693,846USD—-6,156,562USD——
    Unclassified Operating Cash Flow———-5,844,796USD————
    Sale Purchase Of Stock————-442,525USD39,330USD-1,061USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductBone Fusion Products2,855,589USD0001493152-26-022479
    Q1 2026Quarterly · 2026-03-31ProductSoft Tissue Repair Products24,942,945USD0001493152-26-022479
    FY 2025Yearly · 2025-12-31ProductBone Fusion Products11,770,489USD0001493152-26-012352
    FY 2025Yearly · 2025-12-31ProductSoft Tissue Repair Products91,347,493USD0001493152-26-012352
    Q3 2025Quarterly · 2025-09-30ProductBone Fusion Products2,909,693USD0001493152-25-021894
    Q3 2025Quarterly · 2025-09-30ProductSoft Tissue Repair Products23,424,126USD0001493152-25-021894
    Q2 2025Quarterly · 2025-06-30ProductBone Fusion Products3,142,795USD0001493152-25-011885
    Q2 2025Quarterly · 2025-06-30ProductSaa S26,582USD0001493152-25-011885
    Q2 2025Quarterly · 2025-06-30ProductSoft Tissue Repair Products22,661,457USD0001493152-25-011885
    Q2 2025Quarterly · 2025-06-30SegmentSanara Surgical25,804,252USD0001493152-25-011885
    Q2 2025Quarterly · 2025-06-30SegmentTHP26,582USD0001493152-25-011885
    Q1 2025Quarterly · 2025-03-31ProductBone Fusion Products2,901,656USD0001493152-26-022479
    Q1 2025Quarterly · 2025-03-31ProductSoft Tissue Repair Products20,532,440USD0001493152-26-022479
    FY 2024Yearly · 2024-12-31ProductBone Fusion Products10,547,413USD0001493152-26-012352
    FY 2024Yearly · 2024-12-31ProductSoft Tissue Repair Products76,125,012USD0001493152-26-012352
    Q3 2024Quarterly · 2024-09-30ProductBone Fusion Products2,808,264USD0001493152-25-021894
    Q3 2024Quarterly · 2024-09-30ProductSoft Tissue Repair Products18,863,335USD0001493152-25-021894
    Q2 2024Quarterly · 2024-06-30ProductBone Fusion Products2,516,599USD0001493152-25-011885
    Q2 2024Quarterly · 2024-06-30ProductRoyalty906USD0001493152-25-011885
    Q2 2024Quarterly · 2024-06-30ProductSoft Tissue Repair Products17,641,318USD0001493152-25-011885
    Q1 2024Quarterly · 2024-03-31ProductBone Fusion Products2,454,346USD0001641172-25-010254
    Q1 2024Quarterly · 2024-03-31ProductSoft Tissue Repair Products16,082,292USD0001641172-25-010254
    Q4 2023Quarterly · 2023-12-31ProductBone Fusion Products2,559,692USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductRoyalty50,250USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductSoft Tissue Repair Products15,079,871USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductBone Fusion Products9,952,432USD0001641172-25-000632
    FY 2023Yearly · 2023-12-31ProductRoyalty201,000USD0001641172-25-000632
    FY 2023Yearly · 2023-12-31ProductSoft Tissue Repair Products54,836,410USD0001641172-25-000632
    FY 2023Yearly · 2023-12-31SegmentSanara Surgical64,987,112USD0001641172-25-000632
    FY 2023Yearly · 2023-12-31SegmentTHP2,730USD0001641172-25-000632
    FY 2022Yearly · 2022-12-31ProductBone Fusion Products3,987,891USD0001493152-24-011128
    FY 2022Yearly · 2022-12-31ProductRoyalty201,000USD0001493152-24-011128
    FY 2022Yearly · 2022-12-31ProductSoft Tissue Repair Products41,653,954USD0001493152-24-011128
    FY 2021Yearly · 2021-12-31ProductRoyalty Revenue201,000USD0001493152-23-008240
    FY 2021Yearly · 2021-12-31ProductSanara Legacy Product Sales23,942,919USD0001493152-23-008240
    FY 2020Yearly · 2020-12-31ProductProduct Sales Revenue15,385,976USD0001493152-22-008222
    FY 2020Yearly · 2020-12-31ProductRoyalty Revenue201,000USD0001493152-22-008222
    FY 2019Yearly · 2019-12-31ProductProduct Sales Revenue11,607,638USD0001654954-21-003520
    FY 2019Yearly · 2019-12-31ProductRoyalty Revenue159,125USD0001654954-21-003520

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.